Xuexin He

1.1k total citations
31 papers, 770 citations indexed

About

Xuexin He is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Xuexin He has authored 31 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Xuexin He's work include Medical Imaging Techniques and Applications (5 papers), Cancer Treatment and Pharmacology (5 papers) and HER2/EGFR in Cancer Research (5 papers). Xuexin He is often cited by papers focused on Medical Imaging Techniques and Applications (5 papers), Cancer Treatment and Pharmacology (5 papers) and HER2/EGFR in Cancer Research (5 papers). Xuexin He collaborates with scholars based in China, United States and New Zealand. Xuexin He's co-authors include Sai‐Ching J. Yeung, Mong‐Hong Lee, Francisco J. Esteva, Gabriel N. Hortobágyi, Joe Ensor, Jiali Ji, Mei Tian, Shuang Wu, Rui Zhou and Hong Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Xuexin He

29 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuexin He China 13 370 299 215 126 120 31 770
Yunhe Liu China 19 438 1.2× 246 0.8× 164 0.8× 105 0.8× 63 0.5× 51 1.1k
Antonia Gounaris Greece 16 293 0.8× 190 0.6× 195 0.9× 94 0.7× 95 0.8× 35 838
Qiang Sun China 14 339 0.9× 230 0.8× 143 0.7× 131 1.0× 74 0.6× 53 993
Jie Xue China 18 324 0.9× 214 0.7× 306 1.4× 121 1.0× 107 0.9× 48 1.4k
Li Wei China 12 339 0.9× 118 0.4× 93 0.4× 146 1.2× 72 0.6× 40 794
Xuyang Peng China 13 350 0.9× 217 0.7× 82 0.4× 85 0.7× 60 0.5× 27 838
Lijun Ling China 18 180 0.5× 246 0.8× 243 1.1× 73 0.6× 114 0.9× 41 860
Juntian Liu China 21 507 1.4× 606 2.0× 393 1.8× 197 1.6× 42 0.3× 49 1.6k

Countries citing papers authored by Xuexin He

Since Specialization
Citations

This map shows the geographic impact of Xuexin He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuexin He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuexin He more than expected).

Fields of papers citing papers by Xuexin He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuexin He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuexin He. The network helps show where Xuexin He may publish in the future.

Co-authorship network of co-authors of Xuexin He

This figure shows the co-authorship network connecting the top 25 collaborators of Xuexin He. A scholar is included among the top collaborators of Xuexin He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuexin He. Xuexin He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Jing, Chentao Jin, Xiang Zhang, et al.. (2023). Stacking Ensemble Learning–Based [18F]FDG PET Radiomics for Outcome Prediction in Diffuse Large B-Cell Lymphoma. Journal of Nuclear Medicine. 64(10). 1603–1609. 22 indexed citations
3.
Peng, Li‐Ling, Rui Zhou, Yan Zhong, et al.. (2023). [18F]FDG PET/MRI combined with chest HRCT in early cancer detection: a retrospective study of 3020 asymptomatic subjects. European Journal of Nuclear Medicine and Molecular Imaging. 50(12). 3723–3734. 3 indexed citations
4.
He, Xuexin, Sai‐Ching J. Yeung, & Francisco J. Esteva. (2023). A new paradigm for classifying and treating HER2‐positive breast cancer. Cancer Reports. 6(8). e1841–e1841. 3 indexed citations
5.
Zhang, Xiaohui, Han Jiang, Shuang Wu, et al.. (2022). Positron Emission Tomography Molecular Imaging for Phenotyping and Management of Lymphoma. PubMed. 2(2). 102–118. 6 indexed citations
6.
He, Xuexin, Jiali Ji, Aiham Qdaisat, et al.. (2021). Association of Cardiovascular Disease Risk Factors with Late Cardiotoxicity and Survival in HER2-positive Breast Cancer Survivors. Clinical Cancer Research. 27(19). 5343–5352. 8 indexed citations
7.
Li, Binghao, Hao Qu, Jing Zhang, et al.. (2021). Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions. npj Precision Oncology. 5(1). 81–81. 17 indexed citations
8.
9.
Tian, Mei, Xuexin He, Chentao Jin, et al.. (2021). Transpathology: molecular imaging-based pathology. European Journal of Nuclear Medicine and Molecular Imaging. 48(8). 2338–2350. 80 indexed citations
10.
Zhang, Xiaohui, Lin Chen, Han Jiang, et al.. (2021). A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [18F]FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 49(4). 1298–1310. 33 indexed citations
11.
He, Xuexin, Jiali Ji, Mei Tian, et al.. (2019). Long-Term Survival Analysis of Adjuvant Chemotherapy with or without Trastuzumab in Patients with T1, Node-Negative HER2-Positive Breast Cancer. Clinical Cancer Research. 25(24). 7388–7395. 15 indexed citations
12.
Ji, Jiali, et al.. (2018). Primary spinal mucosa-associated lymphoid tissue lymphoma. Medicine. 97(4). e9329–e9329. 3 indexed citations
13.
Dong, Ying, Chao Liang, Bo Zhang, et al.. (2015). Bortezomib enhances the therapeutic efficacy of dasatinib by promoting c-KIT internalization-induced apoptosis in gastrointestinal stromal tumor cells. Cancer Letters. 361(1). 137–146. 9 indexed citations
14.
Xu, Wenhong, Yue Hu, Xuexin He, et al.. (2014). Serum profiling by mass spectrometry combined with bioinformatics for the biomarkers discovery in diffuse large B-cell lymphoma. Tumor Biology. 36(3). 2193–2199. 10 indexed citations
15.
Dong, Ying, Fahuan Song, Xuexin He, et al.. (2014). Small-animal PET demonstrates brain metabolic change after using bevacizumab in a rat model of cerebral ischemic injury. Neuroscience Bulletin. 30(5). 838–844. 4 indexed citations
16.
He, Xuexin, Francisco J. Esteva, Joe Ensor, et al.. (2011). Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer. Annals of Oncology. 23(7). 1771–1780. 176 indexed citations
17.
He, Xuexin, He Huang, Likun Chen, et al.. (2011). A pharmacokinetic and safety study of single dose intravenous combretastatin A4 phosphate in Chinese patients with refractory solid tumours. British Journal of Clinical Pharmacology. 71(6). 860–870. 29 indexed citations
18.
He, Xuexin, et al.. (2011). Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients. Annals of Oncology. 22(12). 2640–2645. 134 indexed citations
19.
Cheang, Maggie C.U., Belén Oliva, Xuexin He, et al.. (2010). Molecular and genomic predictors of response to single-agent doxorubicin (ADR) versus single-agent docetaxel (DOC) in primary breast cancer (PBC).. Journal of Clinical Oncology. 28(15_suppl). 502–502. 9 indexed citations
20.
Zhou, Daixing, et al.. (2008). Changes of c-fos and c-jun mRNA expression in angiotensin II-induced cardiomyocyte hypertrophy and effects of sodium tanshinone IIA sulfonate. Journal of Huazhong University of Science and Technology [Medical Sciences]. 28(5). 531–534. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunhe Liu Breakdown of academic impact, for papers by Antonia Gounaris Breakdown of academic impact, for papers by Qiang Sun Breakdown of academic impact, for papers by Jie Xue Breakdown of academic impact, for papers by Li Wei Breakdown of academic impact, for papers by Xuyang Peng Breakdown of academic impact, for papers by Lijun Ling Breakdown of academic impact, for papers by Juntian Liu
Rankless by CCL
2026